Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (574)
2023 (878)
2022 (829)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (245)
2011 (163)
2010 (139)
All (8207)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
EMBO Mol Med
JSON
ISSN
1757-4684
ISSN-L
1757-4676
IUID
ebdcb44712f24b9c9b39143e381696a5
Modified
2020-11-27T13:14:06.958Z
Created
2017-05-09T09:12:31.821Z
Year 2024
PubMed
DOI
Crossref
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment.
Hunt M
, Wang N, Pupinyo N, ...,
Bachar-Wikstrom E
,
Wikstrom JD
EMBO Mol Med
16
(9) 1986-2001 [2024-09-00; online 2024-07-26]
Bioinformatics Support and Infrastructure [Collaborative]
Bioinformatics Support, Infrastructure and Training [Collaborative]
PubMed
DOI
Crossref
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans.
Wang S
, Nikamo P, Laasonen L, ...,
Ståhle M
,
Tapia-Paez I
EMBO Mol Med
16
(3) 596-615 [2024-03-00; online 2024-02-20]
NGI Short read [Service]
NGI Stockholm (Genomics Production) [Service]
NGI Uppsala (SNP&SEQ Technology Platform) [Service]
National Genomics Infrastructure [Service]
Year 2023
PubMed
DOI
Crossref
A human monoclonal antibody bivalently binding two different epitopes in streptococcal M protein mediates immune function.
Bahnan W,
Happonen L
, Khakzad H, ...,
Malmström J
,
Nordenfelt P
EMBO Mol Med
15
(2) e16208 [2023-02-08; online 2022-12-12]
Structural Proteomics [Collaborative]
Year 2022
PubMed
DOI
Crossref
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.
Kobialka P
,
Sabata H
, Vilalta O, ...,
Castillo SD
,
Graupera M
EMBO Mol Med
14
(7) e15619 [2022-07-07; online 2022-06-13]
Bioinformatics Support for Computational Resources [Service]
Year 2020
PubMed
DOI
Crossref
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.
Rudd SG
, Tsesmetzis N, Sanjiv K, ...,
Helleday T
,
Herold N
EMBO Mol Med
12
(3) e10419 [2020-03-06; online 2020-01-17]
Chemical Biology Consortium Sweden (CBCS) [Collaborative]
Year 2019
PubMed
DOI
Crossref
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
Mohlin S
, Hansson K, Radke K, ..., von Stedingk K,
Bexell D
EMBO Mol Med
11
(8) e10058 [2019-08-00; online 2019-07-16]
NGI Uppsala (Uppsala Genome Center) [Service]
National Genomics Infrastructure [Service]
Structural Proteomics [Service]
Year 2014
PubMed
DOI
Crossref
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.
Ayoglu B, Chaouch A, Lochmüller H, ...,
Nilsson P
, Al-Khalili Szigyarto C
EMBO Mol Med
6
(7) 918-936 [2014-07-00; online 2014-06-13]
Affinity Proteomics Stockholm [Collaborative]
Year 2013
PubMed
DOI
Crossref
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer.
Cepeda D, Ng HF, Sharifi HR, ..., Larsson LG, Sangfelt O
EMBO Mol Med
5
(7) 1067-1086 [2013-07-00; online 2013-06-19]
Tissue Profiling
SciLifeLab Data Centre
Publications
9.5.1